# Safety and Tolerability of ToleroMune Grass in Grass Allergic Subjects With Rhinoconjunctivitis

> **NCT01166061** · PHASE2 · COMPLETED · sponsor: **Circassia Limited** · enrollment: 50 (estimated)

## Conditions studied

- Allergy

## Interventions

- **BIOLOGICAL:** Placebo
- **BIOLOGICAL:** ToleroMune Grass

## Key facts

- **NCT ID:** NCT01166061
- **Lead sponsor:** Circassia Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-07
- **Primary completion:** 2011-04
- **Final completion:** 2011-04
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2011-05-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01166061

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01166061, "Safety and Tolerability of ToleroMune Grass in Grass Allergic Subjects With Rhinoconjunctivitis". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT01166061. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*